An interventional study of Weight loss intervention in Overweight and Obesity, Weight Loss and Pregnancy Related, sponsored by Ulla Kampmann Opstrup. Recruiting at 1 site in Denmark. Open to participants aged 18 Years to 38 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by Ulla Kampmann Opstrup · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 351 studies in Obesity with a site in Denmark — 58 open to participants now, 85 under way, 23 of them phase 3. Obesity · Denmark.
Among the 351 studies in Obesity with a site in Denmark, this one is the 146th largest by planned enrollment of the 283 interventional ones that give a count, is one of 18 that started in 2023, is one of 187 with no phase, reaches primary completion later than 79 of the 84 other live ones, and was the 262nd registered.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
Browse Obesity studies →58 of the 351 studies in Obesity with a site in Denmark are open now. Recruiting first, the newest first:
University Hospital, Gentofte, Copenhagen · Sites in Denmark
Ages 20–40 · Men only · Healthy volunteers
University of Copenhagen · Sites in Denmark
Ages 18–75 · Healthy volunteers
Signe Torekov · Sites in Denmark
Ages 5+ · Healthy volunteers
AstraZeneca · Sites in Denmark, United States, Argentina and 8 more countries
Ages 18+
Novo Nordisk A/S · Sites in Denmark, United States, Belgium and 7 more countries
Ages 18+
A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →
Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.
This study: 18 Years to 38 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
351 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 15 · Phase 2 26 · Phase 3 42 · Phase 4 18
First in 1983; this study’s year is marked. 18 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 66 is close to the median of 67 across 9,043 interventional studies indexed under Obesity.
Median enrollment 72 across the 283 interventional studies, 93 across the 68 observational. Of the 233 that completed or were terminated, 14 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
65 of 351 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Ulla Kampmann Opstrup as lead sponsor.
Ulla Kampmann Opstrup has 1 study filed under Obesity — fewer than ten, so there is no comparison to draw.
14 of the studies in Obesity with a site in Denmark that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06914895Phase 3Eli Lilly and CompanyA Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight | 2026-11 |
| NCT06858839Phase 3AmgenEvaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight | 2027-01-21 |
| NCT06833749KeyBioscience AGEfficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis | 2026-11 |
| NCT07463495University of AarhusThe Metabolic Effects of Oral Tributyrin Administration | 2026-12 |
| NCT06624462Bjorn H. EbdrupEffectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care Clinic | 2026-12 |
Add all 14 to your calendar (.ics) → With an account.
Among the 351 studies in Obesity with a site in Denmark, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study is a single site parallel randomized controlled study. The study will be assessing the effect of a 10% pre-conceptional weight loss intervention vs a control group among healthy couples where the prospective mother is pregnant and overweight or obese (BMI 27-44.9 kg/m\^2). The couples in intervention group will receive dietitian counseling and participate in physical activity sessions to attain the 10% weight loss. The overall objective is to test whether a comprehensive pre-conceptional parental weight loss intervention effectively reduces the risk of offspring overweight, and adiposity and its complications compared to a control group.
The study is a single site parallel randomized controlled study. The study will be assessing the effect of a pre-conceptional weight loss intervention vs a control group among healthy couples where the prospective mother is pregnant (recruited at gestational week 18-36), overweight or obese (BMI 27-44.9 kg/m\^2), between 18-38 years and planning an additional pregnancy within the following 3 years.
The investigators will recruit a total of 66 healthy pregnant couples who will be randomized 1:1 to either intervention or control, stratified according to maternal pre-pregnancy BMI and previous or present diagnosis of gestational diabetes.
The couples in intervention group will receive dietary counseling by a dietitian from 3 months post-partum of the 1st child until birth of the 2nd child. The goal is to achieve a healthy lifestyle and a moderate weight loss of 10% according to pre-pregnancy weight during the first year. Hereafter, the couples will be guided in weight maintenance until pregnancy of the second child. During pregnancy the goal is to achieve a healthy weight gain. Couples in intervention group will also participate in physical activity sessions every 2nd week and will be advised to engage at least 150 minutes of moderate physical activity per week.
The overall objective is to test whether a comprehensive pre-conceptional parental weight loss intervention effectively reduces the risk of offspring overweight, and adiposity and its complications compared to a control group. The 1st baby born before intervention is started will be the "index child" and the metabolic and anthropometric parameters of the 1st child will be compared to parameters of the second child to assess the effect of the parent's healthy lifestyle between the two pregnancies.
The investigators hypothesize that parental weight loss intervention, initiated before conception, will facilitate lower parental insulin resistance, inflammation, body weight and adiposity, incretin responses and energy expenditure compared to usual care. For the offspring the investigators hypothesize that the intervention will reduce adverse pregnancy outcomes with a short-term reduction in the risk of being born large for gestational age with excessive fat mass and a long-term reduction in the risk of developing overweight or obesity as a consequence of both social (family approach) and biological (epigenetic modifications) pathways.
11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.
This study's planned enrollment of 66 is close to the median of 67 across 9,043 interventional studies indexed under Obesity.
Browse Obesity studies →This is the only study on the registry with Ulla Kampmann Opstrup as lead sponsor.
Compared within Obesity, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Overweight. The counts are of registry records indexed under each term, refreshed daily. How we classify →
The criteria were revised on the registry on Nov 12, 2026. See what changed
Maternal inclusion Criteria:
Paternal Inclusion Criteria:
Parental Inclusion Criteria:
Parental Exclusion Criteria:
A detailed description of the exclusion criteria is given below:
Medical conditions as known by the participant:
Medication:
Personal/other:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intervention group will receive dietary counseling by a trained dietitian from 3 months post-partum of the 1st child until birth of the 2nd child. The mother will receive advice to provide a moderate caloric restriction (-500 to 1000 kcal/d) and attend physical activity sessions to attain a 10 % weight loss according to pre-pregnancy weight. If the father is also overweight or obese, he will receive the same advice.
Behavioral: Weight loss intervention
The control group will receive standard care and will not receive any dietary advice prior to pregnancy. During pregnancy control subjects will receive dietary advice according to standard care which means no counselling from a dietitian unless there are special needs (e.g., gestational diabetes), then they will receive counseling from a dietitian in accordance with standard care.
Subjects will receive dietary counseling by a dietitian from 3 months post-partum of the 1st child until birth of the 2nd child. The mother (and father if overweight, BMI ≥25 kg/m\^2) will receive advice to provide a moderate caloric restriction (-500 to 1000 kcal/d) and will be advised to engage in at least 150 minutes of moderate-intensity physical activity per week, including physical activity sessions every 2nd week, with a target weight loss of approximately 0,5-1,0 kg/week. The weight loss will last until a 10% weight loss (according to pre-pregnancy weight) has been achieved or until 1-year post-partum. If the subject has not achieved a weight loss of 10%, she or he will be offered Very low-calorie diet (VLCD) until target weight loss is reached. After weight loss subjects will receive counseling to maintain weight loss and healthy weight gain during pregnancy until birth of the 2nd child.
Neonatal fat mass
Offspring's neonatal fat mass (grams) assessed by air displacement plethysmography (Pea POD)
Time frame: Collected within the first week of birth (strived <48 hours)
Difference in epigenetic changes in child 1 and 2
Cord blood from offspring will be collected at birth and stored at -70 °C or lower until use. At the Department of Molecular Medicine AUH genomic DNA will be extracted and methylation levels are measured using standard arrays and protocols. Methylation levels will be reported as beta-values, reflecting the proportion of methylated CpG sites (range: 0 to 1), assuming a binomial distribution at each site. As no other studies have performed DNA methylation analysis using Illumina EPIC arrays in similar cohorts, precise power calculations are difficult. However, the EPICOM study, which included 20 cases and 20 matched controls, identified several differentially methylated CpGs using a false discovery rate cutoff \<0.05 with the Illumina 450K methylation array. Therefore, we estimate that a sample size of at least 40 cases is needed in our sibling design to be considered sufficient.
Time frame: Assessed at birth
Obstetrics outcome - length of gestational age
Length of gestational age
Time frame: Assessed at birth of both offsprings
Obstetric - medication use
Medication use during labor
Time frame: Collected from initiation of labor until completed birth of both offsprings
Obstetric - delivery mode
Delivery mode (rupture of membranes or premature contractions, vaginal, cesarean section, instrumental delivery, miscarriage and stillbirth).
Time frame: Collected at birth of both offsprings
Obstetric - pregnancy complications
Pregnancy complications e.g. miscarriage, abortion (induced and indication for abortion), hydramnios, gestational hypertension, preeclampsia, need for maternal corticosteroid treatment for fetal lung maturation, urinary tract infection) will be collected from medical record.
Time frame: Collected at gestational age (GA) 34-36 and after birth of both offsprings
Obstetric - Neonatal unit admissions
Neonatal unit admissions
Time frame: Collected at birth and until 12 months after birth of both offsprings
Obstetric - obstetrics complications
Obstetrics complications (e.g. preterm prelabour rupture of the membranes, shoulder dystocia, birth trauma (perinatal rupture), postpartum hemorrhage, maternal infections, maternal hospitalization).
Time frame: Collected at birth of both offsprings
Obstetrics - birth defects/abnormalities
Birth defects/abnormalities
Time frame: Collected at birth of both offsprings
Neonatal morbidities
Neonatal morbidity (e.g. major congenital malformations (ICD10 Q00-Q99 or requiring medical or surgical treatment), birth injury, respiratory distress, transient tachypnoea, neonatal hypoglycemia, systemic infections, admission to neonatal intensive care unit, number of admission days, hyperbilirubinemia), deaths.
Time frame: Collected at birth of both offsprings
Fetal and offspring growth - body weight
Fetal body weight will be measured with ultrasound during pregnancy and offspring body weight will be measured using an electronic scale.
Time frame: Collected from medical record during pregnancy, measured in gestational age (GA) GA34-GA36 via ultrasound in both pregnancies, at birth and 3 and 12 months after birth of both offsprings
Fetal and offspring growth - length
Fetal length will be measured with ultrasound during pregnancy and offspring length will be measured using an infantometer as appropriate for measuring infant, baby and toddler length.
Time frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
Fetal and offspring growth - abdominal circumference
Abdominal circumference will be measured with ultrasound during pregnancy and offspring abdominal circumference will be measured three times to the nearest 0.1 cm using a stretch-resistant measuring tape
Time frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
Fetal and offspring growth - crown circumference
Crown circumference will be measured with ultrasound during pregnancy and offspring crown circumference will be measured three times to the nearest 0.1 cm using a stretch-resistant measuring tape
Time frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies, and measured at birth and 3 and 12 months after birth of both offsprings
Fetal and offspring growth - femur length
Femur length will be measured with ultrasound during pregnancy
Time frame: Collected from medical record during pregnancy, measured in GA34-GA36 via ultrasound in both pregnancies,
Offspring growth - BMI z-score
Offspring body mass index (BMI) z-score (BMI adjusted for age and sex).
Time frame: Collected at birth and 3 and 12 months after birth of both offsprings
Offspring growth - weight for gestational age
Weight for gestational age. Measured as percent of normal weight related to gestational age.
Time frame: Collected at birth and 3 and 12 months after birth of both offsprings
Offspring growth - large for gestational age
Large for gestational age. Prevalence of infants being large for gestational age (LGA).
Time frame: Collected at birth of both offsprings
Offspring growth - small for gestational age
Small for gestational age. Prevalence of offspring being small for gestational age (SGA).
Time frame: Collected at birth of both offsprings
Offspring growth - apgar score
Apgar score (0-10). The higher the score, the better health condition of the offspring)
Time frame: Collected at birth of offspring of both offsprings
Offspring growth
Offspring circumference (thigh, hip and upper arm) and skinfold (subscapularis and suprailiac). Circumferences will be measured to the nearest 0.1 cm using a stretch-resistant measuring tape and skinfolds are measured to the nearest 0.2 mm using a caliper to lightly pinch the skin and the underlying fat.
Time frame: Collected at birth and 3 and 12 months after birth of offspring.
Offspring growth - body composition by the POD system
Offspring fat free mass (g) and fat mass (g) will be assessed by air displacement plethysmography using the POD system (Pea POD for 1-8kg)
Time frame: Collected within the first week of birth and 3 months post partum in both offsprings
Offspring blood pressure
Offspring blood pressure (diastolic and systolic blood pressure) will be measured three times after 10 minutes rest using an automated device placed on the arm and in direct contact with the skin.
Time frame: Collected 12 months after birth of both offsprings
Offspring heart rate
Offspring heart rate will be measured three times after 10 minutes rest using an automated device placed on the arm and in direct contact with the skin.
Time frame: Collected 12 months after birth of both offsprings
Offspring growth - self-reported body weight
Self-reported body weight
Time frame: 4 years after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age
Offspring growth - self-reported height
Self-reported height
Time frame: 4 years after birth the study staff will make an annual follow-up phone call to the parents to collect information about the offspring's self-reported body weight until the offspring is 18 of age
Adult weight
Adult body weight is measured to the nearest 0.1 kg using a calibrated scale
Time frame: Intervention: each visit throughout study (GA34-36 of 1st child to 12 mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3 and 12 months pp of 2nd child)
Adult Height
Adult height will be measured to the nearest 0.5 cm using a wall-mounted stadiometer.
Time frame: Collected in GA34-GA36 in index pregnancy
Adult BMI
Calculated as weight (kg)/height(m)\^2
Time frame: Collected in GA34-36 in 1st pregnancy, study visits 3, 12 and 24mo. pp after 1st child, GA34-36 in 2nd pregnancy and at follow up vist (3 and 12 mo. pp of 2nd child).
Adult anthropometric
Waist- and hip circumference will be measured to the nearest 0.1 cm. During pregnancy and at birth the waist of the female will not be measured.
Time frame: Intervention: each visit throughout study (GA34-36 of 1st child to 12 mo. after birth of 2nd child). Control: In GA34-36 in both pregnancies, at study visits (3, 12 and 24mo. pp) and follow up visits (3 and 12 months pp of 2nd child)
Adult blood pressure
Blood pressure (diastolic and systolic blood pressure) will be measured three times with two minutes apart in right arm after 15 minutes rest using a validated automatic device. The reading is recorded to the nearest 1 mmHg.
Time frame: Collected at GA34-36 in 1st pregnancy, study visits 3, 12 and 24 months pp. of 1st child, GA34-36 in 2nd pregnancy and 3 months pp after 2nd child
Adult heart rate
Heart rate will be measured three times with two minutes apart in right arm after 5-10 minutes rest using a validated automatic device. The reading is recorded to the nearest 1 beats/minute for heart rate
Time frame: Collected at GA34-36 in 1st pregnancy, study visits 3, 12 and 24 months pp. of 1st child, GA34-36 in 2nd pregnancy and 3 months pp after 2nd child
Adult resting metabolic rate
Resting metabolic rate (calories/24-h) will be measured by indirect calorimetry using a ventilated hood system. Participants will lie in the supine position and rest for 15-20 min before measurements commence. The measurement will last for 15 min.
Time frame: Collected at study visit 3, 12, and 24 months pp after 1st child.
Adult resting respiratory quotient + substrate
Resting respiratory quotient (RQ), will be measured by indirect calorimetry using a ventilated hood system. Participants will lie in the supine position and rest for at least 30 min before measurements commence. The measurement will last for 20 min. Lipid, glucose and protein oxidation will be estimated.
Time frame: Collected at study visit 3, 12, and 24 months pp after 1st child.
Adult medication use
Use of medication will be collected throughout the study and for each medication the start date, stop date or continuing, form and indication will be noted in appropriate form.
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st. child
Offspring medication use
Use of medication will be collected throughout the study and for each medication the start date, stop date or continuing, form and indication will be noted in appropriate form.
Time frame: Birth, after 3 and 12 months after birth of both offsprings
Adult reproduction - Time to pregnancy
Duration of time to conception defined from selfreported time point they started to try get pregnant to registration of pregnancy. The time of conception will be calculated from the ultrasound scan in week 12
Time frame: Registration of 2nd. pregnancy (up to tree years from birth of 1.st. child)
Adult glucose metabolism (OGTT)
3-h oral glucose tolerance test (OGTT) will be performed at with 75g of glucose dissolved in 250 ml of water and added 1 gram of paracetamol. Blood will collected for measurements of blood glucose, hormones (insulin, C-Peptide, glucagon), paracetamol, glucagon-like-peptide-1 (GLP-1), Glucose insulinotropic polypeptide (GIP) and metabolites (FFA). Blood samples will be drawn at time 0, 15, 30, 45, 60, 90, 120 and 180 min
Time frame: Performed at study visits 3, 12 and 24 months pp of 1st. child
Adult Oral Glucose Tolerance Test (OGTT) during pregnancy (only female)
OGTT performed during pregnancy according to the screening guidelines for GDM will be obtained from the mother's medical journal in both pregnancies. Performed after risk score at gestational age\~20 and \~28 or only \~28. If, due to weight loss, the participant no longer fulfils the screening criteria for an OGTT in the second pregnancy, she will be offered an OGTT at the same GW as in the first pregnancy as part of the project.
Time frame: Collected in GA28 of 1st and 2nd pregnancy
Placenta - weight (gram)
Placenta weight from patient record will be registered
Time frame: Collected at birth of both offsprings
VO2-max adult - cardiorespiratory fitness
The VO2-max test will be performed as an incremental exercise test on a bicycle ergometer.
Time frame: Collected at study visit 3, 12 and 24 months pp after birth of 1st child
Cardiac function offspring - Left ventricular and right ventricular morphology
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Interventricular septal thickness diastole and valve- and chamber dimensions will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - left centricular ejection fraction
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of left ventricular ejection fraction will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - fractional shortening
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of fractional shortening will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Systolic function, strain
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Systolic function, strain rate
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain rate will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - TAPSE and RV fractional area change
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of TAPSE and RV fractional area change will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Diastolic function, left ventricular E/A-ratio
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of left ventricular E/A-ratio will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Diastolic function, tissue velocities (E', A', S')
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of tissue velocities (E', A', S') will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Diastolic function, strain
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of strain will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Overall cardiac function
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Myocardial performance index (MPI) and cardiac torsion will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Pulmonary artery acceleration time
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Pulmonary artery acceleration time will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Pulmonary artery pressure
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of Pulmonary artery pressure will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cardiac function offspring - Persistent ductus arteriosus (PDA)
ECG and echocardiography will be performed according to standard imaging protocol. Assessment of PDA open or closed and PDA shunt will be done.
Time frame: Collected at birth and at 12 months follow up visit after birth of each child
Cord blood - Telomore length
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Telomore length.
Time frame: Collected at birth of both offsprings
Cord blood - pH
Cord blood pH from patient record will be registered
Time frame: Collected at birth
Cord blood - Epigenetics
Epigenetics analyses from whole blood. Will be analysed for methylation changes. metabolomics and exosome.
Time frame: Collected at birth of both offsprings
Adult body composition by DEXA scan
Lean mass (g), fat mass (g), abdominal fat (g), visceral fat (g) assessed by a Dual-energy X-ray absorptiometry (DEXA) -scan .
Time frame: Collected at study visits 3, 12 and 24 months pp. of 1st child
Adult bone markers by DEXA scan - bone mineral content
Bone mineral content (g) assessed by a Dual-energy X-ray absorptiometry-scan.
Time frame: Collected at study visits 3, 12 and 24 months pp. of 1st child
Adult bone markers by DEXA scan - bone area
Bone area (cm\^2) assessed by a Dual-energy X-ray absorptiometry-scan.
Time frame: Collected at study visits 3, 12 and 24 months pp. of 1st child
Adult bone markers by DEXA scan - bone mineral density
Bone mineral density (g/cm\^2) assessed by a Dual-energy X-ray absorptiometry-scan.
Time frame: Collected at study visits 3, 12 and 24 months pp. of 1st child
Adult blood sample - glucose
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for glucose
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - CD163
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for CD163
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - HbA1c
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for markers of glucose metabolism HbA1c
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Kreatinin
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for kreatinin
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - eGFR
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for kreatinin and GFR will be estimated
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - C-reaktivt protein (CRP)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for CRP
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Alanintransaminase (ALAT)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for ALAT
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Gamma-GT (GGT)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for GGT
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Basisk fosfatase (BASP)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for BASP
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Bilirubin
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Bilirubin
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Ferritin
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Ferritin
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Hemoglobin
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Hemoglobin
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Leukocytter
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Leucocytter
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - platelets
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for platelets
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Triglyceride
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for triglyceride
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Cholesterol HDL
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cholesterol HDL
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Cholesterol LDL
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cholesterol LDL
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Total Cholesterol
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Total Cholesterol
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - vitamin B12
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for B12
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - vitamin D3
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for vitamin D3
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - c-peptide
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for c-peptide
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Insulin-like Growth Factor-1 (IGF-1)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGF-1
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Insulin-like growth factor-binding protein-1 (IGFBP-1)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGFBP-1
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Insulin-like growth factor-binding protein-3 (IGFBP-3)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IGFBP-3
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Fibroblast growth factor 21 (FGF-21)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for FGF-21
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Leptin
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Leptin
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Adiponectin
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Adiponectin
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Ghrelin
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Ghrelin
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Growth Hormone (GH)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for GH
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Free fatty Acids (FFA)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for FFA
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Interleukin 6 (IL-6)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-6
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Interleukin 6 (IL-10)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-10
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Interleukin-1 alpha (IL-1 alpha)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IL-1 alpha
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Interferon gamma (IFN-γ)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for IFN-γ
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult blood sample - Tumor Necrosis Factor alfa (TNF-α)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for TNF-α
Time frame: Collected at GA34-GA36 in 1st pregnancy, study visit 3, 12 and 24 months pp of 1st child, at GA34 in 2nd pregnancy and at follow visit 3 months pp after 2nd child
Adult female blood sample - Humant choriogonadotropin (hCG)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for hCG
Time frame: Collected at GA34-GA36 in both pregnancies
Adult female blood sample - Progesterone
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Progesterone
Time frame: Collected at GA34-GA36 in both pregnancies
Adult female blood sample - Proinsulin C-peptide
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Proinsulin C-peptide
Time frame: Collected at GA34-GA36 in both pregnancies
Adult female blood sample - sex hormone binding globulin (SHBG)
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for SHBG
Time frame: Collected at GA34-GA36 in both pregnancies
Adult female blood sample - Prolactin
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Prolactin
Time frame: Collected at GA34-GA36 in both pregnancies
Adult blood sample -Cortisol
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will be analysed for Cortisol
Time frame: Collected at GA34-GA36 in both pregnancies
Adult female blood sample -Estradiol
All blood samples will be collected by venous puncture in the antecubital vein after an overnight fast from at least 10 pm the night before. Samples will only be collected from the female participant during pregnancy and be analysed for Estradiol
Time frame: Collected at GA34-GA36 in both pregnancies
Offspring blood sample - glucose
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for glucose
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - c-peptide
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for c-peptide
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - insulin
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Insulin
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - IGF-1
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGF-1
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - IGFBP-3
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGFBP-3
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - IGFBP-1
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for IGFBP-1
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - CD163
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for CD163
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Ferritin
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Ferritin
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - HgbA1c
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for HgbA1c
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Hgb
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Hgb
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - CRP
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for CRP
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Triglyceride
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Triglyceride
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Cholesterol HDL
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Cholesterol HDL
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Cholesterol LDL
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Cholesterol LDL
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Total Cholesterol
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Total Cholesterol
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - FGF-21
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for FGF-21
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Leptin
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Leptin
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Adiponectin
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for Adiponectin
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - FFA
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for FFA
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - Growth Hormone (GH)
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for GH
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - cTroponin I (cTnI)
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for cTnI
Time frame: Collected 12 months after birth in both offsprings
Offspring blood sample - BNP
A non-fasting venous blood will be drawn. Parents will be instructed that the offspring should not have eaten two hours prior to the assessment. Samples will be analysed for BNP
Time frame: Collected 12 months after birth in both offsprings
Cord blood - c-peptide
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for C-peptide
Time frame: Collected at birth of both offspring
Cord blood -Insulin
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Insulin
Time frame: Collected at birth of both offspring
Cord blood -IGFBP-3
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGFBP-3
Time frame: Collected at birth of both offspring
Cord blood -IGFBP-1
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGFBP-1
Time frame: Collected at birth of both offspring
Cord blood -IGF-1
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IGF-1
Time frame: Collected at birth of both offspring
Cord blood -Ferritin
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Ferritin
Time frame: Collected at birth of both offspring
Cord blood -cTnI
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for cTnI
Time frame: Collected at birth of both offspring
Cord blood -BNP
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for BNP
Time frame: Collected at birth of both offspring
Cord blood -CRP
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for CRP
Time frame: Collected at birth of both offspring
Cord blood -CD163
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for CD163
Time frame: Collected at birth of both offspring
Cord blood -FGF21
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for FGF21
Time frame: Collected at birth of both offspring
Cord blood -Leptin
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Leptin
Time frame: Collected at birth of both offspring
Cord blood -Adiponectin
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Adiponectin
Time frame: Collected at birth of both offspring
Cord blood -FFA
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for FFA
Time frame: Collected at birth of both offspring
Cord blood - Vitamin D3
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for Vitamin D3
Time frame: Collected at birth of both offspring
Cord blood - HbA1c
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for HbA1c
Time frame: Collected at birth of both offspring
Cord blood - IL-6
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-6
Time frame: Collected at birth of both offspring
Cord blood - IL-10
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-10
Time frame: Collected at birth of both offspring
Cord blood - IL-1 alpha
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IL-1 alpha
Time frame: Collected at birth of both offspring
Cord blood -TNF- alpha
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for-TNF- alpha
Time frame: Collected at birth of both offspring
Cord blood -IFN- gamma
Cord blood will be drawn immediately after birth and analysed. Blood will be analyzed for IFN- gamma
Time frame: Collected at birth of both offspring
Adult Controlled Attenuation Parameter (CAP)
Liver composition is assessed using transient elastography with FibroScan hardware and software. Participants are examined in the supine position to obtain an intercostal view of the liver. Hepatic steatosis is defined as a CAP value \> 250 dB/m.
Time frame: Collected at study visit 3 and 12 months post-partum 1st pregnancy
Adult kilopascal (kPa)
Liver composition is assessed using transient elastography with FibroScan hardware and software. Participants are examined in the supine position to obtain an intercostal view of the liver.
Time frame: Collected at study visit 3 and 12 months post-partum 1st pregnancy
Offspring feces - Microbiome
Will be analysed for microbiome. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring feces - Short chain fatty acids
Will be analysed for short chain fatty acids. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring feces - Metabolomics
Will be analysed for metabolomics. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring feces - Proteomics
Will be analysed for proteomics. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring feces - pH
Will be assessed for pH. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring feces - Inflammation markers
Will be analysed for inflammation markers. Collected at birth by researcher and home by parents preferable \<24 hours before the planned visit.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring feces - consistency
Whenever a fecal sample is collected stool consistency of the collected sample will be collected with a questionnaire.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring feces - frequency
Whenever a fecal sample is collected an estimate of stool frequency during the last week will be collected with a questionnaire.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring feces - gastrointestinal symptoms
Whenever a fecal sample is collected any gastrointestinal symptoms of the offspring during the last week will be collected with a questionnaire.
Time frame: Collected within the first week after birth (but should avoid to collect the first fecal excretion after birth (meconium)), at study visit 3 and 12 months after birth of each offspring
Offspring urine
Parents will be instructed to collect offspring's urine samples. A piece of bio-plastic will be placed in the diaper together with cotton balls to ensure that a sufficient amount of urine is absorbed into the cotton balls. Offspring urine will be analyzed for metabolomics.
Time frame: Collected within the first week of birth and at 3 and 12 months follow up of each offspring
Adult feces - Microbiome
Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for microbiome.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult feces - Short chain fatty acids
Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for short chain fatty acids.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult feces - Metabolomics
Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for metabolomics
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult feces - Proteomics
Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for proteomics.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult feces - Inflammation markers
Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be analysed for inflammation markers.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult feces - pH
Participants will collect a fecal spot sample at home maximum 24 hours before the planned visit. Will be assessed for pH.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult feces - consistency
Whenever a fecal sample is collected stool consistency of the collected sample will be collected with a questionnaire.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult feces - frequency
Whenever a fecal sample is collected an estimate of stool frequency during the last week will be collected with a questionnaire.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult feces - gastrointestinal symptoms
Whenever a fecal sample is collected gastrointestinal symptoms during the last week will be collected with a questionnaire.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Adult urine
Participants will collect a urine spot sample at the study site. Adult urine will be analyzed for metabolomics.
Time frame: Collected at GA34-GA36 in each pregnancy and at study visit 3, 12 and 24 months pp of 1st child
Offspring nutritional milestones
Parents will be instructed to register the age of the offspring when it reaches the World Health Organization (WHO) nutritional milestones (age when the offspring was introduced to specific food items)
Time frame: Collected at 12 and 18 months after offspring birth
Offspring development, WHO milestones
Parents will be instructed to register the age of the offspring when it reaches the World Health Organization (WHO) developmental milestones (age when the offspring can sit, stands in crawl-position, stands with support, stand alone, walk with support, walk alone)
Time frame: Collected at 12 and 18 months after offspring birth
Adult physical activity
Physical activity and sleep will be assessed by an accelerometer and the females and males will wear the accelerometer for 7 days and 8 nights. The participants will be asked to keep a physical activity and sleep log for when they wake up and when they try to sleep
Time frame: Collected at study visit 3, 12 and 24 months pp of 1st child
Adult physical activity - Physical Activity Questionnaire (IPAQ)
Physical activity will be assessed by the International Physical Activity Questionnaire (IPAQ), in which time spent on strenuous and moderate activity and walks will be collected. The answers will be collected electronic via RedCap.
Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child
Adult background quistionnaire, ethnicity,
All information will be collected electronic in RedCap.
Time frame: Collected after screening in GA34-GA36 of 1st child
Adult background quistionnaire, education
All information will be collected electronic in RedCap.
Time frame: Collected after screening in GA34-GA36 of 1st child
Adult background quistionnaire, parity
All information will be collected electronic in RedCap.
Time frame: Collected after screening in GA34-GA36 of 1st child
Adult background quistionnaire, pre-pregnancy weight
Pre-pregnancy weight, ethnicity, education and parity. All information will be collected electronic in RedCap.
Time frame: Collected after screening in GA34-GA36 of 1st child
Adult background quistionnaire, demographic information
All information will be collected electronic in RedCap.
Time frame: Collected after screening in GA34-GA36 of 1st child
Adult wellbeing - Depression, Major depression questionnaire (ICD-10)
Depression will be assessed by Major depression questionnaire (ICD-10). Mild depression: A score of 4 or 5 in two of the first three items. Plus a score of at least 3 on two or three of the last seven items. Moderate depression: A score of 4 or 5 in two or three of the first three items. Plus a score of at least 3 on four of the last seven items. Severe depression: A score of 4 or 5 in all of the first three items. Plus a score of at least 3 on five or more of the last seven items. Major depression: The number of items is reduced to nine, as Item 4 is part of Item 5. Include whichever of the two items has the highest score (item 4 or 5). A score on at least five items is required, to be scored as follows: the score on the first three items must be at least 4, and on the other items at least 3. Either Item 1 or 2 must have a score of 4 or 5.
Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child
Adult wellbeing - Quality of life, Short form-36 (SF-36)
Quality of life will be assessed by the validated tool, Short form-36 (SF-36). The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child
Adult wellbeing - Stress, Perceived Stress Scale
Stress will be assessed by validated tool, Perceived Stress Scale.Individual scores on the PSS can range from 0 to 40 with higher scores indicating higher perceived stress. Scores ranging from 0-13 would be considered low stress. Scores ranging from 14-26 would be considered moderate stress. Scores ranging from 27-40 would be considered high perceived stress
Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child
Adult sleep
Sleep will be assessed by the validated tool, Pittsburgh sleep quality index questionnaire (PSQI). In scoring the PSQI, seven component scores are derived, each scored 0 (no difficulty) to 3 (severe difficulty). The component scores are summed to produce a global score (range 0 to 21). Higher scores indicate worse sleep quality.
Time frame: Collected at GA34-GA36 in each pregnancy, study visit at 3, 12 and 24 months pp of 1st child and 3 months pp visit after 2nd child
Adult dietary intake, 24-h recall
A 24 hour dietary recall is performed by a trained dietitian. Dietary recall will be registered and intake calculated using the food data program 'VITAKOST' (www.vitakost.dk).
Time frame: Collected at GA34-GA36 in each pregnancy, at visit 3, 12 and 24 months pp of the 1st child and 3 months visit after 2nd child. Further collected at 6, 18, 30 and 36 months pp and in GA12 and GA20 of 2nd pregnancy in intervention group
Adult dietary intake, FFQ
Couples will be asked to perform an electronic Food Frequency Questionnaire (FFQ). Information on frequence intake of various food groups during the last month will be collected.
Time frame: Collected at GA34-GA36 in each pregnancy, at study visit 3, 12 and 24 months pp of the 1st child and 3 month follow up vist after 2nd child
Offspring dietary intake
We will collect information on offspring dietary intake including breast feeding, use of formula and type as well as use of antibiotics. The intake frequency of different foods will be collected throughout a children questionnaire.
Time frame: Collected within the first week of birth and 3, 12 and 18 months after birth off each offspring
Breast milk - nutrients biomarkers
Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for nutrients biomarkers.
Time frame: Collected within the first week of birth and 3 months pp after each birth
Breast milk - Hormonal and inflammatory markers
Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for hormonal and inflammatory markers
Time frame: Collected within the first week of birth and 3 months pp after each birth
Breast milk - Metabolomics
Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for metabolomics
Time frame: Collected within the first week of birth and 3 months pp after each birth
Breast milk - Proteomics
Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for proteomics.
Time frame: Collected within the first week of birth and 3 months pp after each birth
Breast milk - Short chain fatty acids and related metabolites
Participants will collect breast milk within the first week following birth, at 1 and 3 months pp after each birth. Participants will receive written instructions in milk collection at home. First drops will not be collected, hereafter manually expressed milk will be obtained in a sterile container. Obtained around midday and minimum two hours after last breastfeeding. Breast milk will be analyzed for short chain fatty acids and related metabolites
Time frame: Collected within the first week of birth and 3 months pp after each birth
Adult participation - dietitian guidance
It will be recorded how many times of individual and group dietitian guidance the participant attends
Time frame: Every 1-2 month from 3 months pp of 1st child to birth of 2nd child
Adult participation - physical session and self-reported physical activity
It will be recorded how many times the participant participates in physical activity sessions and how many minutes of moderate physical activity a participant has performed the last week
Time frame: At every dietitian visit from 3 months pp of 1st child to birth of 2nd child
Plan to share: No
Started Jun 2023 (actual). Primary completion is estimated for Dec 2029, 78 months after the start.
Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 78 months is above that.
Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion Apr 2025 → Dec 2029 and completion Apr 2028 → Dec 2030.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.